Brief: Galecto Reports Second Quarter Operating And Financial Results

Damora Therapeutics

29/07/2022 14:09

July 29 (Reuters) - Galecto Inc  GLTO.O :
    * GALECTO REPORTS SECOND QUARTER OPERATING AND FINANCIAL
RESULTS
    * GALECTO INC - SEES CASH, CASH EQUIVALENTS AND INVESTMENTS
TO BE
SUFFICIENT TO FUND OPERATING EXPENSES AND CAPITAL REQUIREMENTS
INTO SECOND HALF OF 2024
    * GALECTO INC - NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS
FOR
THREE MONTHS ENDED JUNE 30, 2022 WAS $16.9 MILLION OR $0.67 PER
BASIC AND DILUTED SHARE

Source text for Eikon:  ID:nGNX60r2m8 
Further company coverage:  GLTO.O 

 ((Reuters.Briefs@thomsonreuters.com;))